Market closedNon-fractional
Gritstone/GRTS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Gritstone
Gritstone Bio Inc is a biotechnology company. The company is engaged in developing personalized cancer immunotherapies to fight multiple cancer types and infectious diseases. It is building a pipeline of Immunotherapies product candidates for patients with solid tumors, which includes GRANITE, SLATE, and CORAL, among others.
Ticker
GRTS
Sector
Healthcare
Trading on
NASDAQ
Industry
Biotechnology
Headquarters
EmeryVille, United States
Employees
231
Website
gritstonebio.com
Gritstone Metrics
BasicAdvanced
$62M
Market cap
-
P/E ratio
-$1.24
EPS
0.59
Beta
-
Dividend rate
Price and volume
Market cap
$62M
Beta
0.59
Financial strength
Current ratio
2.004
Quick ratio
1.798
Long term debt to equity
690.855
Total debt to equity
739.63
Interest coverage (TTM)
-32.22%
Management effectiveness
Return on assets (TTM)
-52.07%
Return on equity (TTM)
-187.15%
Valuation
Price to revenue (TTM)
4.256
Price to book
4
Price to tangible book (TTM)
4
Price to free cash flow (TTM)
-0.563
Growth
Revenue change (TTM)
2.93%
Earnings per share change (TTM)
-2.88%
3-year revenue growth
-28.32%
3-year earnings per share growth
-4.96%
What the Analysts think about Gritstone
Analyst Ratings
Majority rating from 7 analysts.
Gritstone Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$1.7M
-83.50%
Net income
-$40M
30.84%
Profit margin
-2,370.58%
692.78%
Gritstone Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.31
-$0.33
-$0.26
-$0.34
-
Expected
-$0.35
-$0.33
-$0.33
-$0.32
-$0.30
Surprise
-10.53%
-0.86%
-20.70%
6.79%
-
Gritstone News
AllArticlesVideos
The Schall Law Firm Is Providing Support To Investors To Spearhead The Securities Fraud Legal Action Against Gritstone Bio Inc
Accesswire·4 hours ago
Class Action Filed Against Gritstone bio, Inc. (GRTS) - August 6, 2024 Deadline to Join - Contact Levi & Korsinsky
Accesswire·1 day ago
Levi & Korsinsky Notifies Shareholders of Gritstone bio, Inc.(GRTS) of a Class Action Lawsuit and an Upcoming Deadline
Accesswire·1 day ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Gritstone stock?
Gritstone (GRTS) has a market cap of $62M as of July 06, 2024.
What is the P/E ratio for Gritstone stock?
The price to earnings (P/E) ratio for Gritstone (GRTS) stock is 0 as of July 06, 2024.
Does Gritstone stock pay dividends?
No, Gritstone (GRTS) stock does not pay dividends to its shareholders as of July 06, 2024.
When is the next Gritstone dividend payment date?
Gritstone (GRTS) stock does not pay dividends to its shareholders.
What is the beta indicator for Gritstone?
Gritstone (GRTS) has a beta rating of 0.59. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell Gritstone stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.